Physician profile
Adrienne W Forstner-Barthell
NPI 1033153994
$10,291.20
in general payments reported to CMS, 2019-2025
15 companies · $50.43 in 2025
The $50.43 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,195 · 2020: $243 · 2021: $304 · 2022: $322 · 2023: $22.39 · 2024: $156 · 2025: $50.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,441.43 | 2019-2024 | |
| Medtronic, INC. | $257.43 | 2022-2025 | Interstim |
| Davol INC. | $185.65 | 2019-2021 | |
| Medtronic USA, INC. | $153.54 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $57.62 | 2019-2021 | |
| Axonics, INC. | $45.75 | 2024 | Axonics |
| Ethicon US, LLC | $23.51 | 2020 | |
| Coloplast Corp | $19.49 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $18.54 | 2021 | |
| Allergan, INC. | $18.34 | 2019 | |
| Innocoll Pharmaceuticals Limited | $17.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.65 | 2020 | |
| Braintree Laboratories, INC. | $14.56 | 2021 | |
| Avanos Medical | $12.52 | 2021 | |
| Acell, INC. | $10.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Forstner-Barthell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.